Part 6: Going Remote During COVID-19: Considerations When Moving Studies Out of the Clinic Setting

In this webinar, our panel of experts discuss what you need to know about the impact of COVID-19 on your clinical trials:

Informed consent: what’s allowed and what’s practical in obtaining consent remotely, where does electronic consent come in, and whether participant compensation needs to be modified
How do IRBs consider the review of “virtual” clinical trials?
What do sponsors consider when deciding whether study visits can be conducted remotely, both when planning ahead, and when reacting to urgent issues?

Study Planning & Review